FinnGen Selects Azenta to Propel Personalized Medicine for Population Health Study
Go back to FinnGen Selects Azenta to Propel Personalized Medicine for Population Health Study| AZTECA ACQUISITION CORP (NASDAQ: AZTA) | Delayed: 25.50 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.50 | 52 Week High | $10.45 | |||
| Open | $0.00 | 52 Week Low | $9.73 | |||
| Day High | $25.50 | P/E | 82.26 | |||
| Day Low | $25.50 | EPS | $0.31 | |||
| Volume | 0 | |||||
| (NASDAQ: OLK) | Delayed: 26.08 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $26.08 | 52 Week High | $ | |||
| Open | $0.00 | 52 Week Low | $ | |||
| Day High | $26.08 | P/E | N/A | |||
| Day Low | $26.08 | EPS | $ | |||
| Volume | 0 | |||||
